196 related articles for article (PubMed ID: 6021911)
1. Anaphylatoxin in its relation to the complement system.
Jensen J
Science; 1967 Mar; 155(3766):1122-3. PubMed ID: 6021911
[TBL] [Abstract][Full Text] [Related]
2. COMPONENTS OF GUINEA PIG COMPLEMENT. II. SEPARATION OF SERUM FRACTIONS ESSENTIAL FOR IMMUNE HEMOLYSIS.
LINSCOTT WD; NISHIOKA K
J Exp Med; 1963 Nov; 118(5):795-815. PubMed ID: 14087622
[TBL] [Abstract][Full Text] [Related]
3. COMPONENTS OF GUINEA PIG COMPLEMENT. I. SEPARATION OF A SERUM FRACTION ESSENTIAL FOR IMMUNE HEMOLYSIS AND IMMUNE ADHERENCE.
NISHIOKA K; LINSCOTT WD
J Exp Med; 1963 Nov; 118(5):767-93. PubMed ID: 14087621
[TBL] [Abstract][Full Text] [Related]
4. Anaphylatoxin formation by contact activation of plasma. II. Implication of properdin and an unknown plasma factor in activation by zymosan.
Brade V; Vogt W
Eur J Immunol; 1971 Aug; 1(4):295-300. PubMed ID: 4945686
[No Abstract] [Full Text] [Related]
5. Studies on the relation between the fifth component of complement and anaphylatoxinogen.
Vogt W; Lufft E; Schmidt G
Eur J Immunol; 1971 Apr; 1(2):141-5. PubMed ID: 4108378
[No Abstract] [Full Text] [Related]
6. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement.
Cochrane CG; Müller-Eberhard HJ
J Exp Med; 1968 Feb; 127(2):371-86. PubMed ID: 4383923
[TBL] [Abstract][Full Text] [Related]
7. Chemotactic and anaphylatoxic fragment cleaved from the fifth component of guinea pig complement.
Shin HS; Snyderman R; Friedman E; Mellors A; Mayer MM
Science; 1968 Oct; 162(3851):361-3. PubMed ID: 4175690
[TBL] [Abstract][Full Text] [Related]
8. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. I. Generation of the activated complex.
Miyama A; Kato T; Horai S; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):193-204. PubMed ID: 1218074
[TBL] [Abstract][Full Text] [Related]
9. Complement as a mediator of inflammation. 3. Purification of the activity with anaphylatoxin properties generated by interaction of the first four components of complement and its identification as a cleavage product of C'3.
da Silva WD; Eisele JW; Lepow IH
J Exp Med; 1967 Dec; 126(6):1027-48. PubMed ID: 6069927
[TBL] [Abstract][Full Text] [Related]
10. Simple methods of rabbit hemolytic complement component assays.
Lindorfer JF; Fong JS; Good RA
Int Arch Allergy Appl Immunol; 1974; 46(4):539-51. PubMed ID: 4856448
[No Abstract] [Full Text] [Related]
11. In vivo abrogation of serum C3 and C5 by administration of cobra venom factor and heterologous anti-C3.
Drake WP; Pokorney DR; Mardiney MR
J Immunol Methods; 1974 Dec; 6(1-2):61-72. PubMed ID: 4215835
[No Abstract] [Full Text] [Related]
12. Trypsin-activated complex of human factor B with cobra venom factor (CVF), cleaving C3 and C5 and generating a lytic factor for unsensitized guinea pig erythrocytes. II. Physico-chemical characterization of the activated complex.
Miyama A; Kato T; Yokoo J; Kashiba S
Biken J; 1975 Dec; 18(4):205-14. PubMed ID: 1218075
[TBL] [Abstract][Full Text] [Related]
13. Anaphylatoxin formation by contact activation of plasma. 3. Fixation of two different anaphylatoxin-forming complexes on zymosan.
Brade V; Schmidt G; Vogt W
Eur J Immunol; 1972 Apr; 2(2):180-6. PubMed ID: 4644242
[No Abstract] [Full Text] [Related]
14. Schistosoma mansoni: generation of anaphylatoxin by cercarial extracts.
Gazzinelli G; Ramalho-Pinto FJ; da Silva WD
Exp Parasitol; 1969 Sep; 26(1):86-91. PubMed ID: 5362319
[No Abstract] [Full Text] [Related]
15. Hemolysis of sheep erythrocytes in guinea pig serum deficient in the fourth component of complement. II. Evidence for involvement of C1 and components of the alternate complement pathway.
May JE; Frank MM
J Immunol; 1973 Dec; 111(6):1668-76. PubMed ID: 4750863
[No Abstract] [Full Text] [Related]
16. Purification of a human serum protein ("factor E") which enhances cobra venom factor-induced indirect lysis. Identification with the fifth component of complement.
Lynen R; Vogt W; Schmidt G; Dieminger L
Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):105-16. PubMed ID: 134530
[TBL] [Abstract][Full Text] [Related]
17. Complement-dependent anaphylactic reactions.
Tom BH; Raffel S
Infect Immun; 1975 Jun; 11(6):1284-90. PubMed ID: 1140848
[TBL] [Abstract][Full Text] [Related]
18. Anaphylatoxin release from the third component of human complement by hydroxylamine.
Budzko DB; Müller-Eberhard H
Science; 1969 Aug; 165(3892):506-7. PubMed ID: 5815704
[TBL] [Abstract][Full Text] [Related]
19. Studies on the antigenic properties of complement. II. Analysis of specific agglutinins against certain components of guinea pig complement fixed on sensitized sheep erythrocytes.
KLEIN PG; BURKHOLDER PM
J Exp Med; 1960 Jan; 111(1):107-17. PubMed ID: 14409703
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of anaphylactic histamine release by Forssman antiserum. I. Characteristics of the reaction and inhibitor.
Duravetz J; Baumal R; Broder I
Immunology; 1976 Jan; 30(1):89-99. PubMed ID: 55380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
